摘要
Background Glioblastoma (GBM) is the most common malignant brain tumor with poor clinical outcomes. Immunotherapy has recently been an attractive and promising treatment of extracranial malignancies, however, most of clinical trials for GBM immunotherapy failed due to predominant accumulation of tumor-associated microglia/macrophages (TAMs). Results High level of LRIG2/soluble LRIG2 (sLRIG2) expression activates immune-related signaling pathways, which are associated with poor prognosis in GBM patients. LRIG2/sLRIGs promotes CD47 expression and facilitates TAM recruitment. Blockade of CD47-SIRP alpha interactions and inhibition of sLRIG2 secretion synergistically suppress GBM progression in an orthotropic murine GBM model. Conclusions GBM cells with high level LRIG2 escape the phagocytosis by TAM via the CD47-SIRP alpha axis, highlighting a necessity for an early stage of clinical trial targeting LRIG2 and CD47-SIRP alpha as a novel treatment for patients with GBM.
学科与关键词
- Cancer cell intrinsic TIM-3 induces glioblastoma progressionGuo, Qing; Shen, Shuai; Guan, Gefei; Zhu, Chen; Zou, Cunyi; Cao, Jingyuan; Cheng, Wen; Xu, Xiaoyan; Yu, Juanhan; Lin, Zhiguo; Wang, Guoli; Chen, Ling; Cheng, Peng*; Wu, Anhua*iScience, 2022, 25(11): 105329.被引 9
- Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy?Tong, Ni; He, Zhenqiang; Ma, Yujie; Wang, Zheng; Huang, Ziming; Cao, Haihong; Xu, Lanyang; Zou, Yuheng; Wang, Wanyu; Yi, Chenpeng; Yin, Zhixin; Wang, Qirui*Frontiers in Cell and Developmental Biology, 2021, 9: 706286.被引 40
- Suppression of the hyaluronic acid pathway induces M1 macrophages polarization via STAT1 in glioblastomaYan, Tao; Wang, Kaikai; Li, Jiafeng; Hu, Hong; Yang, He; Cai, Meng; Liu, Ruijie; Li, Honglei; Wang, Ning; Shi, Ying; Hua, Wei; Liu, Huailei*Cell Death Discovery, 2022, 8(1): 193.被引 9
